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Accepted 31 March 2018Background: Cardiac pacing is the treatment of choice for cardioinhibitory carotid sinus syndrome (CSS), but
syncope recurrence occurs in up to 20% of patients within 3 years. The present study aims at assessing incidence
and identifying predictors of syncope recurrence in patients receiving pacing therapy for CSS.
Methods: The Syncope Clinics of two large regional hospitals in Northern Italy, both following European Syncope
Guidelines, combined to perform this study. Retrospective analysis of 3127 consecutive patients undergoing
carotid sinus massage (CSM) was performed 2004–2014. Ten-second supine and standing CSM was systemati-
cally assessed in patients aged N40 years with suspected reflex syncope as part of the initial evaluation. Syncope
recurrence was investigated in those paced for CSS having N6 months' available follow-up. Data were collected
from clinical records and patient interviews.
Results: CSSwas diagnosed in 261 patients (8.3%). Pacemakers were implanted in 158, with follow-up data avail-
able in 112: 19 (17%) experienced 73 syncope recurrences during a mean follow-up of 89± 42months, yielding
an incidence of 0.5 episodes per patient/year. Prodrome, predisposing situations preceding syncope and chronic
nitrate therapy were more frequent in patients reporting recurrence. Prodrome and predisposing situations
remained independent predictors of post-implantation recurrence on multivariable analysis.
Conclusions: CSS is a frequent cause of syncope, if CSM is performed during the initial evaluation. Most patients
treated by pacing remain asymptomatic during long-term follow-up. In those who have recurrence, its incidence
is very low. Prodrome and predisposing situations are predictors of post-implantation recurrence, suggesting
presence of hypotensive susceptibility.
© 2018 Elsevier B.V. All rights reserved.Keywords:
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Carotid sinus syndrome (CCS) is defined as reproduction of spontane-
ous syncope by means of carotid sinus massage (CSM) associated with
asystole N3 s and/or a fall in systolic blood pressure (BP) of N50mmHg
or more [1]. CSS is different from carotid sinus hypersensitivity (CSH)
in which asystole or BP fall are demonstrated on CSM but the patient is
asymptomatic. A highly variable prevalence of CSS is reported in
the literature, ranging from 0% up to 40% [2], due to different patient
selection, timing of CSM or failure to perform CSM during the work-up.ability and freedom from bias of
nsive Care Medicine, University
eggi, Viale Pieraccini 6, 50139Cardiac pacing is the treatment of choice for cardioinhibitory (CI) and
mixed forms and is a Class IIA recommendation in the European Society
of Cardiology (ESC) syncope guidelines [1]; nevertheless, there is still
controversy as to the efficacy of this treatment. The evidence supporting
this recommendation is considered to be weak, with only four random-
ized controlled trials [3–6] and a single randomized, double-blind,
placebo-controlled trial [7] ever reported, presenting conflicting results.
Moreover, syncope recurrence is expected to occur in up to 20% of
patients after pacemaker (PM) implantation [8]. According to the
available literature, mixed CSS and a positive response to Tilt Testing
(TT) are associated with a higher risk of recurrence [9,10], suggesting a
hypotensive underlying mechanism.
The aim of the present study was to assess incidence and identify
predictors of syncope recurrence in patients receiving pacing therapy
for CSS when CSM was performed in patients aged N40 years with
suspected reflex syncope as part of the initial evaluation, as recom-
mended by the ESC guidelines on syncope [1]. Two large regional
120 G. Rivasi et al. / International Journal of Cardiology 266 (2018) 119–123hospitals in Northern Italy participated, both following ESC guidelines
collected the patients who had been referred for investigation of
syncope.
2. Methods
The study population consisted of patients who had received cardiac pacing therapy
because of mixed or cardioinhibitory CSS. We retrieved electronic records concerning
3127 consecutive patients who had undergone CSM in the Syncope Units of Careggi
Hospital, Florence, and Ospedali del Tigullio, Lavagna, Italy in the period 2004–2014.
Patients were referred to the Syncope Unit from the Emergency Department, as inpatients
or from out-of-hospital services, because of syncope, pre-syncope or unexplained falls. All
patients were evaluated according to the ESC guidelines protocol [1] and CSM was per-
formed in patients aged N40 years with suspected reflex syncope after initial evaluation
(which consisted of clinical history, physical examination, standard 12 lead electrocardio-
gram, blood pressure measurement in supine and upright positions). Clinical history was
aimed at assessing characteristics of spontaneous episodes, including presence of vasova-
gal prodrome (blurring/clouded vision, light-headedness, loss of balance, pallor, sweating,
etc.) and the following predisposing situations for reflex syncope: hot and crowded envi-
ronment, emotional distress (including intense pain, blood and instrumentation),
prolonged standing, typical trigger for situational syncope (micturition, defaecation,
cough, post-exercise and post-prandial).
CSMwas performed according to the ESC guidelines technique [1]: longitudinal mas-
sage was applied for 10 s over the point of maximum carotid impulse (between the angle
of the jaw and the cricoid cartilage, on the anterior margin of the sternocleidomastoid
muscle), on the right and then left side. Patients had supine and then erect CSM, using a
motorized footplate tilt table with an angle of 60°. The time interval between massages
had to be long enough for baseline heart rate (HR) and BP to be restored. In accordanceTable 1
Comparison between paced patients with and without syncope recurrence during a 3.8 ± 3.4
Mean follow-up, months ± SD
Mean age, years ± SD
Male sex, n (%)
Number of syncope before PM, median (IQR)
Number of syncope episodes in the 2 years before evaluation, median (IQR)
Incidence of syncope episodes in the 2 years before evaluation, n/year
History of syncope (years), median (IQR)
Hypertension, n (%)
Diabetes, n (%)
Falls, n (%)
Orthostatic hypotension, n (%)
Heart disease, n (%)
Presyncope, n (%)
Prodrome, n (%)
Prodrome N10 s, n (%)
Prodrome b10 s, n (%)
Predisposing situations for VVS, n (%)
Hospitalization for syncope, n (%)
Injuries, n (%)
Digitalis, n (%)
ACEi/ARB, n (%)
β-Blockers, n (%)
Calcium channel antagonists, n (%)
Alpha-receptor blockers, n (%)
Nitrates, n (%)
Diuretics, n (%)
Antiarrhythmic drug, n (%)
Other hypotensive drugs, n (%)
Abnormal ECG, n (%)
Atrial fibrillation, n (%)
Left bundle branch block, n (%)
Right bundle branch block alone, n (%)
Right and anterior fascicular block, n (%)
I degree atrio-ventricular block, n (%)
Cardioinhibitory CSS, n (%)
Mixed CSS, n (%)
Asystole duration, seconds ± SD
Tilt table test: performed, pts. n (%)
– of whom positive responses, pts. n (%)
– VASIS I, n (%)
– VASIS II (A + B), n (%)
– VASIS III, n (%)
SD, standard deviation; PM, pacemaker; VVS, vasovagal syncope; ACEi, angiotensin-converting
ECG, electrocardiogram.with the “Method of Symptoms” [11], CSH was diagnosed if CSM elicited abnormal
cardioinhibition (asystole ≥3 s) and/or vasodepression (systolic BP fall ≥50 mm Hg); if
spontaneous symptoms were reproduced in the presence of CSH, CSS was diagnosed.
Asymptomatic CSHwas not considered diagnostic owing to its low specificity [12]. A tran-
sient ischaemic attack, stroke or a myocardial infarction over the previous three months
was a contraindication to CSM. In case of carotid bruit, patientswere referred for a Doppler
ultrasound; if a carotid stenosis N70% was detected, CSM was not performed. In order to
investigate the susceptibility to orthostatic stress, the evaluation was completed by
means of TT performed according to the Italian protocol [13]; positive responses were
defined according to the VASIS classification (Vasovagal Syncope International Study)
[14]. CSM and TTwere performedunder continuous electrocardiogram and BPmonitoring
(Task Force® monitor, CNSystems Medizintechnik AG, Graz, Austria). Written informed
consent for the procedures was obtained from each participant.
2.1. Treatment and follow-up
Enrolled patients had received a dual-chamber pacemaker. Outcome of the study was
recurrence of syncope after pacemaker implantation. Syncopal recurrencewas investigated
by retrieving clinical records and patient interviews, by telephone or during clinic visits.
2.2. Statistical analysis
Data are reported as amean± standard deviation,medianwith interquartile range or
as percentage, as appropriate. The Fisher exact text was used to compare dichotomous
variables; the Student t-test for unpaired data was used to compare continuous data
with normal distribution; the non-parametric Mann–Whitney test for unpaired data
was used to compare continuous data with not normal distribution. A multivariable anal-
ysis by Cox logistic regression of predictors of syncope recurrence was performed among
those variables listed in Table 1 that had a P value ≤0.1 at univariable analysis. The hazardyear follow-up (min N6months).
All patients
(n = 112)
Recurrence
(n = 19)
No recurrence
(n = 93)
P
71 ± 43 89 ± 42 68 ± 43 0.06
77.1 ± 9.7 78.3 ± 6.5 76.9 ± 10.2 0.6
77 (69) 10 (53) 67 (72) 0.09
2 (1;3) 3 (1;3.5) 2 (1;3) 0.3
2 (1;2) 2 (1;3) 1 (1;2) 0.5
0.91/year 1.03/year 0.88/year
1 (0.5;4) 1 (1;5.5) 1 (0.5;4) 0.9
52 (46.4) 9 (47.4) 43 (46.2) 0.9
23 (20.5) 3 (15.8) 20 (21.5) 0.6
21 (18.8) 4 (21.1) 17 (18.9) 0.8
35 (31.2) 5 (26.3) 30 (32.3) 0.6
37 (33.0) 7 (36.8) 30 (32.3) 0.7
45 (40.2) 7 (36.8) 38 (40.9) 0.7
72 (64.3) 16 (84.2) 56 (60.2) 0.04
29 (25.9) 9 (47.4) 20 (21.5) 0.02
43 (38.4) 7 (36.8) 36 (38.7) 0.9
20 (17.9) 6 (31.6) 14 (15.1) 0.08
29 (25.9) 3 (15.8) 26 (28.0) 0.3
39 (34.8) 5 (26.3) 34 (36.6) 0.4
6 (5.4) 1 (5.3) 5 (5.4) 0.9
51 (45.5) 11 (57.9) 40 (43.0) 0.2
24 (21.4) 6 (31.6) 18 (19.4) 0.2
18 (16.1) 5 (26.3) 13 (14.0) 0.2
18 (16.1) 2 (10.5) 16 (17.2) 0.5
7 (6.3) 3 (15.8) 4 (4.3) 0.05
27 (24.1) 6 (31.6) 21 (22.6) 0.4
3 (2.7) 1 (5.3) 2 (2.15) 0.4
15 (13.4) 3 (15.8) 12 (12.9) 0.7
58 (51.8) 10 (52.6) 48 (51.6) 0.9
12 (10.7) 1 (5.3) 11 (11.8) 0.4
8 (7.1) 3 (15.8) 5 (5.4) 0.1
10 (8.9) 1 (5.3) 9 (9.7) 0.3
12 (10.7) 1 (5.3) 11 (11.8) 0.7
18 (16.1) 1 (5.3) 17 (18.3) 0.2
81 (72.3) 14 (73.7) 67 (72.0) 0.8
31 (27.8) 5 (26.3) 26 (28.0) 0.8
7.0 ± 2.5 6.8 ± 1.6 7.1 ± 2.7 0.9
89 (79%) 17 (89%) 72 (77%) 0.3
44 (49.4) 9 (53) 35 (48.6) 0.5
19 (21.3) 4 (23.5) 15 (20.8) 0.6
8 (8.9) 0 (0.0) 8 (11.1) 0.11
17 (19.1) 5 (29.4) 12 (16.6) 0.3
enzyme inhibitors; ARB, angiotensin receptor antagonists; CSS, carotid sinus syndrome;
Table 2
Multivariable Cox logistic regression analysis: predictors of recurrence.
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be statistically significant. Analyses were performed using Statistica version 8.0 (StatSoft
Italia, Padova, Italy).Variables HR (95.0% CI) P
Prodrome 5.10 (1.12–23.29) 0.04
Predisposing situations 3.76 (1.07–13.16) 0.04
Chronic nitrate therapy 6.17 (0.91–41.8) 0.06
Females 2.56 (0.79–8.33) 0.12
Duration of follow-up 1.01 (0.99–1.02) 0.173. Results
Of a total of 3127 consecutive patients who underwent CSM for
suspected reflex syncope after initial evaluation (1272 patients evalu-
ated in Florence and 1855 in Lavagna), CSS was diagnosed in 261
patients (8.3%): 141 (54%) had CI, 88 (33.7%) had mixed and 32 (12%)
had vasodepressor forms. A pacemaker was implanted in 158 (69%)
of those with CI or mixed form who potentially had an indication for
pacing; these patients form the study group. In the remaining patients,
reasons for not implanting a pacemaker were physician's decision or
refusal by the patient. Their clinical characteristics are compared in
Supplementary Table 1. Moreover, 46 patients were lost to follow-up
before 6 months, thus finally 112 paced patients in whom follow-up of
≥6 months was available were included for analysis (Fig. 1). The base-
line clinical features of the study population are listed in Table 1. The
study participants and patients lost to follow-up had comparable char-
acteristics, with the exception of prolonged prodrome and right bundle
branch block, which had a higher prevalence in the study population;Fig. 1. Screening log of patients who had undergone carotid sinus massage at the Syncope Uni
CI-CSS, cardio-inhibitory carotid sinus syndrome; M-CSS, mixed CSS; VD-CSS, vasodepressor Cthe median number of syncope episodes before PM implantation was
higher in patients lost to follow-up (Supplementary Table 1).
During a mean follow-up of 89 ± 42months, a total of 73 episodes
of syncope recurred in 19/112 patients (17%) with a median of 2
(IQR 2; 4.5) episodes per patient, yielding an incidence of 0.5 episodes
per patient/year of follow-up. At univariable analysis, patients with
syncope recurrence more frequently had prodrome, often prolonged,
predisposing situations preceding syncope and chronic nitrate therapy.
On the contrary, neither the type of response during CSM (CI versus
mixed) nor a positive response during TT were able to identify patients
with syncope recurrence. At the multivariate Cox logistic regression
model, prodrome and predisposing situations remained independent
predictors of syncope recurrence (Table 2).t of Firenze and Lavagna. CSM, carotid sinus massage; CSH, carotid sinus hypersensitivity;
SS.
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Syncope recurrence after cardiac pacing occurred in 17% of patients
having CSS, consistent with previous studies [15,16]. We showed that
both prodrome and predisposing situations for reflex syncope are asso-
ciated with a higher risk of syncope recurrence after pacing therapy for
mixed or CI-CSS. These predictors can be easily assessed from medical
history, allowing the clinician to identify patients at higher risk of recur-
rence, before cardiac pacing is performed.
The present study validated the indication for CSM given by the ESC
guidelines on syncope [1]. In accordance with those guidelines, CSM
was systematically performed after initial evaluation in patients aged
N40 years with suspected reflex syncope, after cardiac aetiology had
been excluded. In this clinical context, CSS was diagnosed in 8.3% of
patients and 60.5% of them received pacing therapy. With the above
indications, CSM may increase the diagnostic yield of initial evaluation,
guide patients' therapeutic management and avoid execution of other
more complex tests.
Performing CSM in accordance with these indications and the
restrictive diagnostic criteria of the “Method of Symptoms”, cardiac pac-
ing was fairly effective in this large population during a long follow-up:
syncope never recurred in the majority of patients and, in the minority
who had some recurrence, the incidence fell 10-times from 1.03/year
before pacemaker implantation to 0.1/year after the implantation.
Admittedly, not being a controlled trial, we are not able to ascertain
the relative contribution of other factors to the decrease in recurrence
rate. It is a common finding that syncopal recurrences often decrease
spontaneously after medical assessment [17], even in the absence of a
specific therapy; in general syncope recurs in b50% of patients within
1–2 years and, if recurrence occurs, the burden of syncope decreases
even N70% compared with the preceding period. In a study by Solari
et al. [9] evaluating patients affected by CSS, the yearly syncope burden
decreased by a similar magnitude in patients treated with a pacemaker
as well as in patients treated with discontinuation/reduction of hypo-
tensive therapies and in those left untreated. Several potential clinical,
statistical and psychological explanations have been provided and
each of them probably plays a role: patient education and reassurance,
an expectation effect or a regression-to-the-mean effect [18].
The mechanism of syncope recurrence after pacemaker implanta-
tion may be unclear. PM malfunction is reported to be very rare in
these patients [19]. Contrary to other studies in the literature, we
were unable to show an increased rate ofmixed CSS [10,19] and positive
TT [9,15,20] in our patients who had recurrence; the reason is unclear.
Nevertheless, some hypotensive susceptibility, which is frequent in
patients with reflex syncope, is likely to be involved [21]. The presence
of prodrome and/or predisposing situations for reflex syncope suggests
that a pronounced hypotensive susceptibility is present, so caution is
recommended before referring the patient for pacing therapy. Indeed,
hypotensive susceptibility is uninfluenced by pacing and requires
specific treatment. Therefore, each patient should receive lifestyle
counselling concerning early recognition of prodromal symptoms,
prevention of typical predisposing situations and performance of
counter-pressure manoeuvres. In addition, reduction or withdrawal
of hypotensive therapy should be considered, particularly in cases of
polypharmacy; indeed, vasoactive drugs may exacerbate hypotensive
susceptibility, particularly in older patients, due to an age-related reduc-
tion in peripheral alpha-adrenergic response to orthostatism. In our
study population, chronic nitrate therapywasmore common in patients
with syncope recurrence. Reducing or discontinuing hypotensive ther-
apymay help prevent syncope recurrence, particularly in older patients,
as a recent study confirms [22].
4.1. Limitations
This is a retrospective study in which no diaries of symptoms were
collected by patients, so a wrong or inaccurate recall cannot beexcluded; in addition, the precise date and time to syncope recurrence
could not be evaluated, thus we were unable to build survival analysis
curves. During follow-up, the effects of hypotensive therapy reduction
or withdrawal were not investigated, as well as presyncope or minor
symptom recurrence.
All the patients were followed periodically in the pacemaker clinic.
No data concerning alternative diagnoses was reported. Of course, we
cannot exclude that a more accurate reappraisal would have been able
to determine associated conditions which could have been responsible
for recurrence of syncope. In our study population TT was not able to
predict post-implantation recurrence. This result could be related to a
reduced sample size: indeed, TT was performed in 17 of 19 patients
with recurrence and only 9 positive responses were observed.
Unfortunately, a relevant percentage of paced patients was lost to
follow-up, probably due to the retrospective design of our study and
the prolonged enrollment period. Not all the patients with a diagnosis
of CI or mixed CSS made at initial evaluation finally received a pace-
maker therapy. Owing to its retrospective design we can only speculate
on the patient's or physician's reasons for not implanting a pacemaker
in about one third of them (Fig. 1). They differ for several baseline clin-
ical baseline characteristics from those who implanted a pacemaker
(see Supplementary Table 1).
5. Conclusions
In case of suspected reflex syncope after the initial evaluation,
carotid sinus massage provides a diagnosis of carotid sinus syndrome
in 8.3% of patients; the majority of those affected by CI or mixed form
received pacing therapy (69%). Cardiac pacing is the treatment of choice
for cardioinhibitory carotid sinus syndrome, but syncope recurrence
may occur. Prodrome and spontaneous episodes occurring in typical
predisposing situations for reflex syncope are predictive of post-
implantation recurrence but not a positive tilt test. These predictors
can easily be assessed frommedical history and are suggestive of hypo-
tensive susceptibility, which should receive specific treatment.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcard.2018.03.144.
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